Antibody Production Strategic Research Report 2024-2030 - Rising Adoption of Antibody-Drug Conjugates (ADCs) Drives Innovation in Next-Generation Antibody Production Platforms

Understand the significant growth trajectory of the Monoclonal Antibody segment, which is expected to reach US$27.4 Billion by 2030 with a CAGR of a 9.8%. The Polyclonal Antibody segment is also set to grow at 12.7% CAGR over the analysis period. Gain insights into the U.S. market, estimated at $4.7 Billion in 2023, and China, forecasted to grow at an impressive 14.0% CAGR to reach $8.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Anti ...